The store will not work correctly when cookies are disabled.
N-Hydroxy-5-((1-oxoisoindolin-2-yl)methyl)-[1,1'-biphenyl]-2-carboxamide
ID: ALA4776127
PubChem CID: 162643277
Max Phase: Preclinical
Molecular Formula: C22H18N2O3
Molecular Weight: 358.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NO)c1ccc(CN2Cc3ccccc3C2=O)cc1-c1ccccc1
Standard InChI: InChI=1S/C22H18N2O3/c25-21(23-27)19-11-10-15(12-20(19)16-6-2-1-3-7-16)13-24-14-17-8-4-5-9-18(17)22(24)26/h1-12,27H,13-14H2,(H,23,25)
Standard InChI Key: ZLQGJCXVOFYHBM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
30.1942 -12.8146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9007 -12.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6096 -12.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4504 -12.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1149 -13.6287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3162 -13.8011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9066 -13.0948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0919 -13.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6859 -13.8055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1005 -14.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9138 -14.5065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2776 -11.6832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6101 -13.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3182 -14.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0257 -13.6207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0206 -12.7993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3119 -12.3966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7351 -14.0262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7387 -14.8434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4411 -13.6146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1505 -14.0201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7236 -12.3889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4343 -12.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1388 -12.3821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1340 -11.5641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4186 -11.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7170 -11.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 7 1 0
6 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 12 2 0
3 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 3 1 0
15 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
16 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.40 | Molecular Weight (Monoisotopic): 358.1317 | AlogP: 3.63 | #Rotatable Bonds: 4 |
Polar Surface Area: 69.64 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.94 | CX Basic pKa: ┄ | CX LogP: 3.24 | CX LogD: 3.23 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: -0.64 |
References
1. Mak JYW,Wu KC,Gupta PK,Barbero S,McLaughlin MG,Lucke AJ,Tng J,Lim J,Loh Z,Sweet MJ,Reid RC,Liu L,Fairlie DP. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates., 64 (4.0): [PMID:33570940] [10.1021/acs.jmedchem.0c01967] |